CyberKnife Cancer Institute of Chicago Is the First to Offer CyberKnife Treatment in the City of Chicago
CHICAGO, Aug. 30, 2012 /PRNewswire/ -- CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital, is the first and only center within the City of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery treatment. The 10,000 sq. ft. state-of-the-art facility is treating patients with cancers of the brain, spine, pancreas, prostate, kidney, liver and lung. The technology is also effective for certain nervous system conditions like trigeminal neuralgia and arteriovenous malformations. The center is supported throughout the Chicagoland area by 24 credentialed physicians as well as a partnership with Radiology Oncology, S.C., a division of Alpha Med Physicians Group.
As a non-invasive alternative to surgery, CyberKnife Robotic Radiosurgery can effectively treat complex tumors located virtually anywhere in the body. These treatments offer a reduced the risk of complications, allow the treatment of recurrent tumors, and are comfortable procedures that can usually be completed in around an hour per treatment.
"We are thrilled to have CyberKnife technology in Chicago and conveniently on Chicago's Magnificent Mile. It grants us the opportunity to treat patients with the most revolutionary tumor technology available for a higher level of patient care and ultimately treatment success," says Dr. Adam Dickler, Medical Director of the CyberKnife Cancer Institute of Chicago.
To learn more about CyberKnife and locate a referring physician, visit www.ckcancerchicago.com.
About CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital
CyberKnife Cancer Institute of Chicago is the only center within the city of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery s